STAAR Surgical (STAA) News Today

Mutual of America Capital Management LLC reduced its stake in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 85.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,408 shares of the medical instruments supplier's stock after sel

Susquehanna Fundamental Investments LLC acquired a new stake in STAAR Surgical (NASDAQ:STAA - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 71,339 shares of the medical instruments su

Needham & Company LLC reiterated a "hold" rating on shares of STAAR Surgical in a research report on Monday.

STAAR Surgical (NASDAQ:STAA - Get Free Report) has been assigned a consensus rating of "Hold" from the eleven analysts that are currently covering the stock, MarketBeat reports. Six analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company

Geneva Capital Management LLC reduced its stake in STAAR Surgical (NASDAQ:STAA - Free Report) by 22.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 711,194 shares of the medical instruments

STAAR Surgical (NASDAQ:STAA) Trading Up 8.3%

STAAR Surgical (NASDAQ:STAA) Stock Price Down 3.3%

Vanguard Group Inc. raised its position in STAAR Surgical (NASDAQ:STAA - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,468,710 shares of the medical instruments s

STAAR Surgical (NASDAQ:STAA) Trading Down 6.9%

STAAR Surgical (NASDAQ:STAA) Trading 8.6% Higher

STAAR Surgical (NASDAQ:STAA - Free Report) - Equities researchers at William Blair reduced their FY2024 EPS estimates for STAAR Surgical in a research report issued on Thursday, June 20th. William Blair analyst M. Kaczor now expects that the medical instruments supplier will post earnings of $0.1

STAAR Surgical (NASDAQ:STAA - Get Free Report) has earned an average rating of "Hold" from the eleven analysts that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the

STAAR Surgical (NASDAQ:STAA) Stock Price Down 4.9%

Broadwood Capital Inc. boosted its holdings in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 13.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,537,835 shares of the medical instruments supplier's stock after pu

Caxton Associates LP bought a new position in shares of STAAR Surgical (NASDAQ:STAA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 62,413 shares of the medical instruments su

STAAR Surgical (NASDAQ:STAA) Shares Gap Up to $38.07

BTIG Research raised STAAR Surgical from a "neutral" rating to a "buy" rating and set a $46.00 target price on the stock in a research report on Tuesday.

Seven Eight Capital LP raised its stake in STAAR Surgical (NASDAQ:STAA - Free Report) by 47.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 67,885 shares of the medical instruments supplier's stock after pur

Insider buying, where company executives or board members purchase shares of their own company, can be a significant indicator for investors. It often suggests that those closest to the company's operations have confidence in its future performance.

Insider buying might signal confidence and a bullish outlook for investors. Four stocks with heavy insider buying include DLTR, TALO, STAA, and RXO.

Norges Bank bought a new stake in STAAR Surgical (NASDAQ:STAA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 436,223 shares of the medical instruments supplier's stoc

Trexquant Investment LP decreased its position in STAAR Surgical (NASDAQ:STAA - Free Report) by 68.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,554 shares of the medical instruments supplier's stock after sellin

Principal Financial Group Inc. decreased its stake in STAAR Surgical (NASDAQ:STAA - Free Report) by 38.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 281,007 shares of the medical

STAAR Surgical (NASDAQ:STAA - Get Free Report) has earned an average recommendation of "Hold" from the ten brokerages that are covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The av

Jackson Square Partners LLC reduced its stake in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 18.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,694,992 shares of the medical instruments supplier'

Jump Financial LLC lessened its stake in STAAR Surgical (NASDAQ:STAA - Free Report) by 34.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 46,330 shares of the medical instruments supplier's stock after selling 24,139 shares during the q

Geneva Capital Management LLC cut its holdings in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 918,156 shares of the medical instruments su

Canaccord Genuity Group cut their price objective on STAAR Surgical from $46.00 to $43.00 and set a "hold" rating for the company in a research report on Wednesday.

Piper Sandler increased their price objective on STAAR Surgical from $33.00 to $40.00 and gave the company a "neutral" rating in a research report on Wednesday.

STAAR Surgical (NASDAQ:STAA) Trading Down 8.7% After Earnings Miss

STAAR Surgical (NASDAQ:STAA - Get Free Report) released its quarterly earnings data on Tuesday. The medical instruments supplier reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.12). STAAR Surgical had a return on equity of 8.73% and a net margin of 6.62%. The company had revenue of $77.40 million during the quarter, compared to analysts' expectations of $75.34 million. During the same quarter in the prior year, the company posted $0.05 EPS. The company's revenue for the quarter was up 5.3% on a year-over-year basis.

STAAR Surgical (NASDAQ:STAA) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=305604)